文献速递肝肾功能剂量调整治疗药物监测与药物基因组学

华法林动力学-药效学模型用于日本患者PT-INR预测

Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients.
PubMed 文献 · Br J Clin Pharmacol · 2023-12-10

本研究基于350例日本成人患者2762次PT-INR测量, refined华法林动力学-药效学模型,纳入年龄及CYP2C9和VKORC1基因型,发现EDR50随体表面积、血清白蛋白和eGFR呈幂函数变化。蒙特卡洛模拟显示eGFR越低,达到目标PT-INR所需华法林日剂量越低,提示模型引导精准给药有助于肾功能不全患者剂量估计。

要点

  • EDR50随体表面积、血清白蛋白和eGFR呈幂函数变化
  • eGFR降低时达到目标PT-INR所需华法林日剂量更低
  • 模型引导精准给药可用于肾功能不全患者华法林剂量估计

核心结论

  • 模型引导的华法林精准给药是估计肾功能不全患者剂量的有价值方法。

研究设计与样本

  • 回顾性队列研究,纳入350例接受华法林并测量PT-INR的成人患者(>20岁),共2762次PT-INR测量。
  • 使用非线性混合效应模型程序的PRIOR子程序,结合年龄及CYP2C9和VKORC1基因型refined动力学-药效学模型。
  • 采用逐步前向-后向法筛选参数(如EDR50)的显著协变量,并用蒙特卡洛模拟确定目标PT-INR范围所需的华法林日剂量。

主要发现

  • 最终模型显示EDR50随体表面积、血清白蛋白水平和eGFR呈幂函数变化。
  • 蒙特卡洛模拟显示,随着eGFR降低,达到目标PT-INR范围(2.0-3.0或1.6-2.6)所需的华法林日剂量更低。

关键数值与推荐

  • 目标PT-INR范围为2.0-3.0或1.6-2.6。
  • 纳入患者eGFR为47.5(范围2.6-199.0)mL/min/1.73 m2。

临床怎么用

  • 对于肾功能不全患者,可参考基于eGFR等协变量的模型预测华法林剂量,以更精准地达到目标PT-INR。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Genotype-guided dosing algorithms can explain about half of the interindividual variability in prothrombin time-international normalized ratio (PT-INR) under warfarin treatment. This study aimed to refine a published kinetic-pharmacodynamic model and guide warfarin dosage for an optimal PT-INR based on renal function. METHODS: Using a retrospective cohort of adult patients (>20 years) who were administered warfarin and underwent PT-INR measurements, we refined the kinetic-pharmacodynamic model with age and the genotypes of cytochrome P450 2C9 and vitamin K epoxide reductase complex subunit 1 using the PRIOR subroutine in the nonlinear-mixed-effect modelling programme. We searched the significant covariates for parameters, such as the dose rate for 50% inhibition of coagulation (EDR50 ), using a stepwise forward and backward method. Monte Carlo simulation determined a required daily dose of warfarin with a target range of PT-INR (2.0-3.0 or 1.6-2.6) based on the significant covariates. RESULTS: A total of 350 patients with 2762 PT-INR measurements were enrolled (estimated glomerular filtration rate [eGFR]: 47.5 [range: 2.6-199.0] mL/min/1.73 m2 ). The final kinetic-pharmacodynamic model showed that the EDR50 changed power functionally with body surface area, serum albumin level and eGFR. Monte Carlo simulation revealed that a lower daily dose of warfarin was required to attain the target PT-INR range as eGFR decreased. CONCLUSIONS: Model-informed precision dosing of warfarin is a valuable approach for estimating its dosage in patients with renal impairment.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Hirai T, Aoyama T, Tsuji Y, et al. Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients. Br J Clin Pharmacol. 2023. PMID: 37953511. doi:10.1111/bcp.15967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。